UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

PloS one, 2020-06, Vol.15 (6), p.e0234683-e0234683

2020

Volltextzugriff (PDF)

Higher doses of naloxone are needed in the synthetic opiod era

Substance abuse treatment, prevention and policy, 2019-02, Vol.14 (1), p.6

2019

Volltextzugriff (PDF)

Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

Clinical immunology (Orlando, Fla.), 2021-10, Vol.231, p.108828-108828, Article 108828

2021

Volltextzugriff (PDF)

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

PloS one, 2009-11, Vol.4 (11), p.e7838-e7838

2009

Volltextzugriff (PDF)

A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection

The Journal of infectious diseases, 2012-12, Vol.206 (12), p.1844-1851

2012

Volltextzugriff (PDF)

Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector

Annals of allergy, asthma, & immunology, 2018-05, Vol.120 (5), p.540-541

2018

Volltextzugriff (PDF)

Enterovirus 68 Infection–Association with Asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2016-03, Vol.4 (2), p.226-228

Moss, Ronald B.

2016

Volltextzugriff (PDF)

Human Factors Study of a Newly Approved Epinephrine Prefilled syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB39-AB39

2018

Volltextzugriff (PDF)

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein

PloS one, 2009-11, Vol.4 (11), p.e7788-e7788

2009

Volltextzugriff (PDF)

The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys

Molecules (Basel, Switzerland), 2020-03, Vol.25 (6), p.1360

2020

Volltextzugriff (PDF)

The use of sialidase therapy for respiratory viral infections

Antiviral research, 2013-06, Vol.98 (3), p.401-409

2013

Volltextzugriff (PDF)

Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxis

Allergy and asthma proceedings, 2018-09, Vol.39 (5), p.389-393

2018

Volltextzugriff (PDF)

Anaphylaxis: getting to the point (and price) of diagnosis and treatment

Journal of asthma and allergy, 2018-01, Vol.11, p.109-110

Moss, Ronald B

2018

Volltextzugriff (PDF)

Targeting pandemic influenza: a primer on influenza antivirals and drug resistance

Journal of antimicrobial chemotherapy, 2010-06, Vol.65 (6), p.1086-1093

2010

Volltextzugriff (PDF)

An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects

Journal of opioid management, 2020-05, Vol.16 (3), p.209-214

2020

Volltextzugriff (PDF)

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Vaccine, 2010-03, Vol.28 (13), p.2565-2572

2010

Volltextzugriff (PDF)

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

Clinical infectious diseases, 2011-10, Vol.53 (7), p.e77-e80

2011

Volltextzugriff (PDF)

Prospects for control of emerging infectious diseases with plasmid DNA vaccines

Journal of immune based therapies and vaccines, 2009-09, Vol.7 (1), p.3-3

Moss, Ronald B

2009

Volltextzugriff (PDF)

Emergence of Hemagglutinin Mutations During the Course of Influenza Infection

Scientific reports, 2015-11, Vol.5 (1), p.16178-16178, Article 16178

2015

Volltextzugriff (PDF)

Higher doses of naloxone are needed in the synthetic opioid era

Substance abuse treatment, prevention and policy, 2019-02, Vol.14 (1), p.1-6, Article 6

2019

Volltextzugriff (PDF)

Treatment of Resistant Influenza Virus Infection in a Hospitalized Patient with Cystic Fibrosis with DAS181, a Host-Directed Antiviral

Antiviral therapy, 2016-01, Vol.21 (1), p.71-74

2016

Volltextzugriff (PDF)

CD8+ T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligodeoxynucleotides

Journal of Virology, 2005-01, Vol.79 (1), p.393-400

2005

Volltextzugriff (PDF)

Mucosal Immunization with Inactivated Human Immunodeficiency Virus plus CpG Oligodeoxynucleotides Induces Genital Immune Responses and Protection against Intravaginal Challenge

The Journal of infectious diseases, 2002-10, Vol.186 (8), p.1098-1105

2002

Volltextzugriff (PDF)

Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma

Journal of allergy and clinical immunology, 2005-12, Vol.116 (6), p.1343-1349

2005

Volltextzugriff (PDF)

2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients

Infectious Diseases: Research and Treatment, 2012-05, Vol.2012 (2012), p.33-42

Moss, Ronald B.

2012

Volltextzugriff (PDF)

1 – 25 von 799

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(661)
Mit Volltextzugriff
(606)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(487)
Life Sciences & Biomedicine
(410)
Humans
(384)
Female
(273)
Biological And Medical Sciences
(259)
Male
(257)
Adult
(220)
Medical Sciences
(215)
Middle Aged
(158)
Aged
(123)
Animals
(99)
Risk Factors
(99)
Endocrinopathies
(84)
Diabetes. Impaired Glucose Tolerance
(81)
Endocrine Pancreas. Apud Cells
(81)
Ophthalmology
(80)
Wisconsin - Epidemiology
(77)
Diabetic Retinopathy - Epidemiology
(73)
Adolescent
(65)
Associated Diseases And Complications
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

Higher doses of naloxone are needed in the synthetic opiod era

Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection

Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector

Enterovirus 68 Infection–Association with Asthma

Human Factors Study of a Newly Approved Epinephrine Prefilled syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein

The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys

The use of sialidase therapy for respiratory viral infections

Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxis

Anaphylaxis: getting to the point (and price) of diagnosis and treatment

Targeting pandemic influenza: a primer on influenza antivirals and drug resistance

An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

Prospects for control of emerging infectious diseases with plasmid DNA vaccines

Emergence of Hemagglutinin Mutations During the Course of Influenza Infection

Higher doses of naloxone are needed in the synthetic opioid era

Treatment of Resistant Influenza Virus Infection in a Hospitalized Patient with Cystic Fibrosis with DAS181, a Host-Directed Antiviral

CD8+ T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligodeoxynucleotides

Mucosal Immunization with Inactivated Human Immunodeficiency Virus plus CpG Oligodeoxynucleotides Induces Genital Immune Responses and Protection against Intravaginal Challenge

Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma

2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients

Suchergebnisse filtern